RVTY
XNYSRevvity, Inc.
Technology · Laboratory Analytical Instruments
$92.30
+5.79 (+6.69%)
15-min delayed
Drag to pan · Scroll to zoom · Hover for OHLC
Snapshot
Loading metrics…
About Revvity, Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Employees
11,000
Country
US
IPO Date
1972-06-01
Recent News
Revvity, Inc. Q1 2026 Earnings Call Summary
Yahoo · 14h ago
Revvity (RVTY) Q1 2026 Earnings Transcript
Yahoo · 15h ago
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
Yahoo · 16h ago
Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics
Yahoo · 17h ago
Revvity Q1 Earnings Call Highlights
Yahoo · 18h ago
Revvity (NYSE:RVTY) Beats Q1 CY2026 Sales Expectations
Yahoo · 19h ago
Revvity (RVTY) Q1 Earnings and Revenues Top Estimates
Yahoo · 19h ago
Revvity, Inc. 2026 Q1 - Results - Earnings Call Presentation
SeekingAlpha · 20h ago
Analyst Ratings
Loading…
Financials
Loading SEC filings…
Insider Activity
Loading filings…
Related Stocks
Loading peers…
Data is 15-minute delayed, for informational purposes only. Not investment advice. Prices via Massive.com consolidated feed. Fundamentals via FinancialModelingPrep. News via Finnhub.